A lentiviral vector-based vaccine

Details for Australian Patent Application No. 2006310173 (hide)

Owner Institut Pasteur

Inventors Despres, Philippe; Charneau, Pierre

Agent Fisher Adams Kelly

Pub. Number AU-B-2006310173

PCT Pub. Number WO2007/052165

Priority 11/250,616 17.10.05 US

Filing date 17 October 2006

Wipo publication date 10 May 2007

Acceptance publication date 3 May 2012

International Classifications

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/052165 Priority application(s): WO2007/052165

3 May 2012 Application Accepted

  Published as AU-B-2006310173

30 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006310176-Fed batch culture methods for streptococci

2006310171-Cell-derived viral vaccines with low levels of residual cell DNA by betapropiolactone treatment